Hydrea is a prescription antimetabolite used to inhibit cell proliferation in certain malignancies. Its active metabolite hydroxyurea penetrates cells and suppresses dna synthesis by blocking ribonucleotide reductase. This leads to reduced replication of fast dividing tumor cells and temporary suppression of the immune system. The drug is primarily prescribed for chronic myelogenous leukemia and certain hemoglobin disorders requiring increased fetal hemoglobin production. Pharmacologically it diffuses through plasma, enters erythrocytes and marrow precursors, and exerts cytotoxic and immunomodulatory effects. The overall therapeutic action results from decreased dna replication rates and selective killing of proliferating cells.

Hydrea is a medication that contains hydroxyurea which works by reducing the production of dna in rapidly dividing cells. It is used primarily to treat certain cancers such as chronic myelogenous leukemia by slowing the growth of abnormal blood cells. The drug interferes with the enzyme ribonucleotide reductase causing a depletion of deoxythymidine triphosphate and leading to dna damage in cancer cells. This mechanism results in the death of malignant cells and a decrease in disease progression. Hydrea also increases fetal hemoglobin levels which helps improve oxygen transport in patients with sickle cell disease. Overall the medication acts as an antimetabolite that modifies dna synthesis to achieve its therapeutic effects.

The most common side effects are generally mild and short lived. They often include headache soreness and fatigue. Some people experience nausea or dizziness. Muscle aches may occur occasionally. Dry mouth is also reported frequently. Transient fever can appear in a small number of cases. These effects typically resolve without intervention.

The most common side effects include headache and muscle aches. Some people experience mild nausea and occasional dizziness. Fatigue and a dry mouth are also frequently reported. A mild fever and temporary blurred vision may occur. These reactions are usually short lived and do not require treatment. Severity can vary from person to person. Most individuals notice improvement as the body adjusts. Serious complications are rare and are monitored by health professionals.